Business Wire

WA-AUTH0

Share
Auth0 Public Sector Index Shows Governments Struggle to Provide Trustworthy Online Citizen Services

Auth0 , a product unit within Okta (NASDAQ: OKTA), today released the findings of its first Public Sector Identity Index , a global research report that provides government technology leaders with insight into the identity maturity of public sector organizations around the world. The report highlights the importance of a centralized identity strategy in putting safe and accessible services into the hands of citizens faster.

Over the past two years, many public sector organizations were prompted by the immediate need to deploy digital infrastructure to maintain continuity of their services amid the COVID-19 pandemic — such as offering citizens license renewals online and virtual education — and are now grappling with the impacts on cybersecurity and user experience. From the Executive Order on ‘Improving the Nation’s Cybersecurity’ in the U.S., to digital identity and Single Sign-On (SSO) initiatives in the UK and Australia, enabling employees, citizens, and other government entities to access all of these applications easily and securely has become a demand around the world.

The 2022 Public Sector Identity Index, conducted by Auth0 and Market Connections , captures the perceptions of 850 IT and line of business decision-makers within national and state/local government organizations across the U.S., UK, and ANZ (Australia and New Zealand) with regard to their Identity and Access Management (IAM) strategy.

The report’s key findings include:

  • Only one in five are extremely confident in either the security (17%) or ease of use (19%) of their current authentication solution.
  • Username and password is the most frequently used authentication method by citizens (86%), compared to very little usage of biometric or passwordless authentication (16%).
  • Four in ten are currently building their own IAM solution in-house (41%), and cite speed to implementation (83%) and using internal staff to manage IAM internally (82%) as two of the biggest pain points in doing so.
  • Most governments are looking to expand their digital services in the next two years (75%) and rank protecting citizen’s privacy and data as most important when thinking about citizen services (73%).

Regional analysis shows U.S. respondents rank ensuring citizens’ trust in digital services as an area of high importance (71%), but have less confidence in their organization’s ability to deliver this (56%). Similar discrepancies in importance versus confidence in delivery include speed in adding new services in the UK (66% importance vs. 48% confidence), and improving the user experience in ANZ (72% importance vs. 60% confidence).

Dean Scontras, Vice President of State and Local Government and Education (SLED) at Okta, said: “Digitization is likely to continue in light of Zero Trust mandates and mounting consumer expectations. Public sector organizations greatly benefit from bringing their identity management strategy in line with their digital goals. While there is a strong focus on securing citizen data, the vast majority of applications are still protected by a username and password, despite their well-documented security risks.”

According to Forrester Research, the public sector has a massive influence on the entire economy making up 30% of the global GDP and 33% of the global workforce, and the global research firm predicts that more governments will adopt Zero Trust frameworks to revive public trust in digital services.1

An Identity-First approach puts identity at the center of government digital transformation, while also laying the foundation for a Zero Trust security model. Key to this approach are modern login technologies that replace traditional passwords, and introduce friction only when suspicious behavior is detected. By making the shift to Identity-First, organizations like Larimer County provide easy and seamless access for legitimate users, while decreasing the risk of security and compliance breaches.

Jessica Figueras, a cybercrime and digital identity advisor to governments and Okta consultant, said: “In the face of increasing digitization, skills shortages, and online harms, governments are taking a hard look at the technologies they can bring onboard to help them reach their digital goals. The research suggests that identity is one such technology that can help the public sector do more with less.”

To learn more and download the full report, please visit: 2022 Auth0 Public Sector Identity Index .

Methodology

Auth0 engaged Market Connections to design an online survey of 850 IT and line of business decision-makers within national and state/local governments in the U.S. (200 federal, 200 state & local), UK (100 federal, 100 state & local), and ANZ (Australia and New Zealand) (155 federal/national, 95 state & local), fielded in September-October 2021.

About Auth0

Auth0, a product unit within Okta, takes a modern approach to identity and enables organizations to provide secure access to any application, for any user. The Auth0 Identity Platform is highly customizable, and is as simple as development teams want, and as flexible as they need. Safeguarding billions of login transactions each month, Auth0 delivers convenience, privacy, and security so customers can focus on innovation. For more information, visit https://auth0.com .

About Okta

Okta is the leading independent identity provider. The Okta Identity Cloud enables organizations to securely connect the right people to the right technologies at the right time. With more than 7,000 pre-built integrations to applications and infrastructure providers, Okta provides simple and secure access to people and organizations everywhere, giving them the confidence to reach their full potential. More than 14,000 organizations, including JetBlue, Nordstrom, Siemens, Slack, Takeda, Teach for America, and Twilio, trust Okta to help protect the identities of their workforces and customers.

Disclaimer:

Research reports and related summaries referenced herein are provided for informational purposes only, and consist of the opinions of the organizations publishing such research and should not be construed as statements of fact. Okta and Auth0 make no representations, warranties, or other assurances with respect to such research.


1 Public Sector Predictions 2022, Forrester Research, Inc., November 3, 2021.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment17.9.2025 14:00:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC’s multi-brand strategy in the rapidly expanding aesthetic medicine market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917897380/en/ SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment As life expectancy continues to rise and demographic aging accelerates, more people are seeking treatments that help them maintain both well-being and a youthful appearance over a longer lifespan. Within this environment, aesth

Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board17.9.2025 14:00:00 CEST | Press release

IND clearance marks second study accepted for RLS-1496, a first-in-class disease-modifying selective GPX4 modulator targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases and conditions associated with the biological aging process through ferroptosis Results from first RLS-1496 study in patients with psoriasis, atopic dermatitis, and skin aging are expected in Q4 2025; the actinic keratosis Phase 1b/2a study will begin in Q4 2025 Rubedo Clinical Advisory Board expands to include globally renowned dermatologist and immunologist Emma Guttman-Yassky, MD, PhD., Waldman Professor of Dermatology and Immunology and Health System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that the U.S

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs17.9.2025 14:00:00 CEST | Press release

Universal Surveillance Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost Savings Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire demonstrated that use of Masimo technologies to continuously monitor general floor patients can yield significant cost savings.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917266545/en/ Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ In prior studies, the clinical outcome benefits of continuously monitoring patients using Masimo SET® and Patient SafetyNet™ have been shown to include lower mortality, improved resuscitative outcomes, and fewer rapid response team activations and transfers

Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 202517.9.2025 14:00:00 CEST | Press release

Four-year data show nearly 9 in 10 RMS patients remained free from progression independent of relapse activity (PIRA)Results highlight the potential of MAVENCLAD to reduce neurodegeneration and neuroinflammation beyond established clinical efficacy outcomes in RMSEvidence suggests that MAVENCLAD effectiveness could be driven by peripheral and central effects without requiring continuous immunosuppression Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New four-year data from two large Phase 4 studies highlight the long-term efficacy, favorable disability outcomes and durable impact of MAVENCLAD® (cladribine tablets) in people living with relapsing multiple sclerosis (RMS). These findings are to be presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), being held September 24-26 in

Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand17.9.2025 13:30:00 CEST | Press release

Kinectrics, a division of BWX Technologies Inc. (NYSE: BWXT), announced today the completion of a major expansion to its isotope production capabilities, reinforcing its role as a global supplier of highly enriched stable isotopes and establishing the only North American source for Yb-176, reducing the reliance on foreign material for life-saving cancer treatments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917450864/en/ Travis Besanger, Kinectrics VP of Medical Isotopes, speaking within the new Isotope Separation Production Facility at Kinectrics Headquarters in Toronto, Canada. Kinectrics commissioned four new 2nd generation Electromagnetic Isotope Separator (EMIS) units, which will boost its annual production capacity to over 500 grams of Ytterbium-176 (Yb-176), the precursor for Lutetium-177 (Lu-177), by the end of the year. This scaled output will support over 150,000 patient treatments annually. Lu-177 is a medi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye